LIVE MARKET TRACKER :   BSE SENSEX   22876.54      |    NSE NIFTY 6840.80    
GLOBAL MARKETS :  NASDAQ 4126.967   -0.83%    |    FSI London 6674.74   -0.11%    |    NIKKEI Japan 14404   -0.98%
  USD GBP EUR CAD AUD INR
USD - 0.5958 0.7239 1.1029 1.0767 61.06
GBP 1.6785 - 1.215 1.8513 1.8072 102.491
EUR 1.3816 0.8231 - 1.5238 1.4875 84.3593
CAD 0.9068 0.5402 0.6564 - 0.9763 55.3666
AUD 0.929 0.5535 0.6724 1.0246 - 56.7217
INR 0.0164 0.0098 0.0119 0.0181 0.0176 -
Indian-Commodity  :  Equity & Shares  :  Dr Reddy's Lab gains on introducing PamorelinO LA - cancer drug

Dr Reddy's Lab gains on introducing PamorelinO LA - cancer drug (10-Dec-2012)

Dr Reddy's Lab is currently trading at Rs. 1845.00, up by 6.65 points or 0.36% from its previous closing of Rs. 1838.35 on the BSE.

The scrip opened at Rs. 1844.80 and has touched a high and low of Rs. 1846.95 and Rs. 1833.70 respectively. So far 1923 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1850.00 on 06-Dec-2012 and a 52 week low of Rs. 1528.00 on 19-Jun-2012.

Last one week high and low of the scrip stood at Rs. 1850.00 and Rs. 1804.00 respectively. The current market cap of the company is Rs. 31,321 crore.

The promoters holding in the company stood at 25.56% while Institutions and Non-Institutions held 39.75% and 17.76% respectively.

Dr Reddy's Laboratories, has introduced PamorelinO LA in India under an exclusive marketing and sales agreement with Debiopharm Group, Switzerland. The company will import this drug in bulk from Debio Recherche Pharmaceutique and made available primarily to urologists and oncologists across India. PamorelinO LA is used for the treatment of locally advanced or metastatic, hormone-dependent prostate cancer.

Dr Reddy's is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs 


Top News Today
Gems and jewellery exports decline by around 9% to $39.5 billion in FY14
(21-Apr-2014)

Gems and jewellery exports decline by around 9% to $39.5 billion in FY14India's gems and jewellery exports fell by about 9 percent to $39.5 billion during the fiscal year 14 as compared to $43.34 billion in the previous fiscal. The exports of gems and jewellery, which contribute......click on news to read complete article.

IMC to discuss upon coal bidder's concern in its meeting on Thursday
(17-Apr-2014)

IMC to discuss upon coal bidderWith the government having initiated the process of auctioning coal blocks, bidders have raised concerns on several serious and trivial issues, including discrepancies in reserves in the biggest of the......click on news to read complete article.

Retail Inflation snaps three months easing trend at 8.31% in March
(16-Apr-2014)

Retail Inflation snaps three months easing trend at 8.31% in MarchQuestioning the assumptions which that worst is over for Asia's third-largest economy, the provisional annual inflation rate based on all India general Consumer Price Index (CPI) (Combined) disappointed......click on news to read complete article.

International Stock News
Asian markets trade mostly lower in early deals on Thursday
(24-Apr-2014)

Asian markets trade mostly lower in early deals on ThursdayMost of the Asian equity benchmarks are trading lower in early deals on Thursday, tracking cues from Wall Street where profit-taking and a somewhat disappointing March housing data dragged down stocks.......click on news to read complete article.

US markets gain; S&P 500 marks longest rally in 2014
(23-Apr-2014)

US markets gain; S&P 500 marks longest rally in 2014The US markets closed higher on Tuesday, with the S&P 500 extending its winning streak to sixth day, the longest streak of gains since September 2013. On the economy front, the Federal Housing......click on news to read complete article.

US markets gain; S&P marks longest winning streak in 6 months
(22-Apr-2014)

US markets gain; S&P marks longest winning streak in 6 monthsThe US markets closed higher on Monday, with investors back into action after the long holiday weekend, helping the S&P 500 to extend its winning streak to the longest in six months. On the economic......click on news to read complete article.

 

     
  
Recent Equity & Shares News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.